Data-focused CRO Quanticate names new COO
Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Lee Patterson as the company's Chief Operating Officer (COO). Prior to Quanticate, Patterson served...
ViiV Healthcare continues innovative partnership to transform HIV care
ViiV Healthcare and Chelsea and Westminster Hospital NHS Foundation Trust are continuing their innovative partnership to transform HIV patient care with the launch of...
Next stage of COVID-19 vaccination programme begins
The NHS has begun the next stage of its vaccine roll-out programme to a further two priority groups today - those aged 70 and...
NICE recommendation for GSK’s ovarian cancer treatment
National Institute for Health and Care Excellence (NICE) has recommended GSK’s ZEJULA®▼ (niraparib) on the NHS in England for women with advanced high-grade epithelial...
Victims of abuse given code word to ask pharmacists for help
Victims of domestic abuse will be able to access much needed support from thousands of pharmacies across the UK, in a new scheme backed...
Positive trial results for Eli Lilly’s Donanemab in Alzheimer’s
A positive Phase 2 Trial of Eli Lilly’s donanemab, an investigational antibody, has shown significant slowing of decline in a composite measure of cognition...
Doctor Care Anywhere strengthens mental health support
One of the UK's leading providers of digital health services, Doctor Care Anywhere, is collaborating with Koa Health, a digital mental health care provider...
ViiV Healthcare meets milestone in treatment of paediatric patients
Global specialist HIV company, ViiV Healthcare has been granted Marketing Authorisation by the European Commission for Tivicay (dolutegravir) 5mg dispersible tablets, as treatment for...
Boehringer Ingelheim joins forces with Google
Boehringer Ingelheim has become the first pharmaceutical company worldwide to join forces with Google in quantum computing. The partnership will focus on researching and...
Sanofi acquires immune and inflammatory disease specialist Kymab
Sanofi has acquired Kymab, a clinical-stage biopharmaceutical company based in Cambridge, developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology...
Latest articles
Nearly one-third of cervical cancer Phase III clinical trials expected to conclude in 2021
Data and analytics company GlobalData has revealed that out of the 107 ongoing clinical trials worldwide for cervical cancer, 30% are estimated to be...
Merck discontinues development of its COVID-19 vaccines
Merck, known as MSD outside the United States and Canada, has announced that the company is discontinuing development of its two COVID-19 vaccine candidates,...
COVID-19 vaccination programme ramps up with 30 new centres
More than 30 new NHS Vaccine Centres will start delivering COVID-19 jabs this week as the health service continues to accelerate the biggest immunisation...
Popular articles
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
JCVI updates priority list for COVID-19 vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of...
Isle of Man set to become world-leading exporter of medicinal cannabis
The Isle of Man Government has passed new regulations to create a comprehensive framework to issue licenses for the production, distribution and export of...